SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-22-007292
Filing Date
2022-09-28
Accepted
2022-09-28 16:00:43
Documents
82
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ipix_10k.htm   iXBRL 10-K 1619311
2 CONSENT ipix_ex231.htm EX-23.1 1982
3 CERTIFICATION ipix_ex311.htm EX-31.1 9972
4 CERTIFICATION ipix_ex321.htm EX-32.1 4954
  Complete submission text file 0001477932-22-007292.txt   6666833

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ipix-20220630.xsd EX-101.SCH 95541
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20220630_lab.xml EX-101.LAB 422700
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20220630_cal.xml EX-101.CAL 56134
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20220630_pre.xml EX-101.PRE 360680
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20220630_def.xml EX-101.DEF 243958
76 EXTRACTED XBRL INSTANCE DOCUMENT ipix_10k_htm.xml XML 910416
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-37357 | Film No.: 221275957
SIC: 2834 Pharmaceutical Preparations